Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05600556

Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)

Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 20

Sponsor: Thomas Jefferson University

Location: United States

Summary

This clinical trial explores if using virtual reality (VR) headsets will help to improve patient understanding of their disease and decrease anxiety about treatment. Three-dimensional (3D) images may help the patient visualize their tumor and location better and therefore understand potential side effects. Visualizing a virtual representation of the magnetic resonance imaging (MRI) linear accelerator (Linac) may decrease treatment related anxiety.

Eligibility Criteria

Inclusion Criteria:Age: above 18 yearsParticipants must be histologically proven neoplasmPlanned to undergo radiation treatment using the MR LinacExclusion Criteria:Inability to tolerate virtual reality headsetNon-English speaking patientsPediatric patients are ineligible

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05600556). StuddyBuddy aggregates publicly available trial information.